| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 766516 | 90024 | COLECALCIFEROL NORMON 25.000 UI/2,5 ML SOLUCIÓN ORAL | COLECALCIFEROL NORMON 25.000 UI/2,5 ML SOLUCIÓN ORAL, 1 Frasco de 2,5 ml | 25.000 UI | 6 | 1 | 17 | 1 Frasco de 2,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90024/90024_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90024/90024_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2024-12-20 | 1 | 1 | 1 | 2024-12-21 | 2024-12-20 | 0 | 2025-02-11 | View Edit Delete | ||||||||||||
| 766517 | 90024 | COLECALCIFEROL NORMON 25.000 UI/2,5 ML SOLUCIÓN ORAL | COLECALCIFEROL NORMON 25.000 UI/2,5 ML SOLUCIÓN ORAL, 4 frascos de 2,5 ml | 25.000 UI | 6 | 4 | 17 | 4 frascos de 2,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90024/90024_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90024/90024_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2024-12-20 | 1 | 1 | 1 | 2024-12-21 | 2024-12-20 | 0 | 2025-02-11 | View Edit Delete | ||||||||||||
| 765972 | 14300 | ELIGARD SEMESTRAL 45 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ELIGARD SEMESTRAL 45 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 jeringa precargada + 1 jeringa precargada de disolvente | 45 mg | 33 | 1 | 61 | 1 jeringa precargada + 1 jeringa precargada de disolvente | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/14300/14300_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2359 | MELYFARMA S.L. | 2024-10-15 | 1 | 1 | 1 | 2024-10-16 | 2024-10-15 | 0 | 2025-01-09 | View Edit Delete | ||||||||||||
| 765805 | 72972 | DURFENTA 50 microgramos/HORA PARCHES TRANSDERMICOS EFG | DURFENTA 50 microgramos/HORA PARCHES TRANSDERMICOS EFG, 10 parches | 50 microgramos/h | 35 | 10 | 28 | 10 parches | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72972/72972_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72972/72972_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1625 | ESPECIALIDADES FARMACEUTICAS CENTRUM S.A. | 2012-05-29 | 1 | 1 | 1 | 2012-05-29 | 2024-09-23 | 0 | 2026-03-06 | Lista I | View Edit Delete | |||||||||||
| 765806 | 72973 | DURFENTA 75 microgramos/HORA PARCHES TRANSDERMICOS EFG | DURFENTA 75 microgramos/HORA PARCHES TRANSDERMICOS EFG, 10 parches | 75 microgramos/h | 35 | 10 | 28 | 10 parches | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72973/72973_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72973/72973_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1625 | ESPECIALIDADES FARMACEUTICAS CENTRUM S.A. | 2012-05-29 | 1 | 1 | 1 | 2012-05-29 | 2024-09-23 | 0 | 2026-03-06 | Lista I | View Edit Delete | |||||||||||
| 765807 | 72971 | DURFENTA 25 microgramos/HORA PARCHES TRANSDERMICOS EFG | DURFENTA 25 microgramos/HORA PARCHES TRANSDERMICOS EFG, 10 parches | 25 microgramos/h | 35 | 10 | 28 | 10 parches | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72971/72971_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72971/72971_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1625 | ESPECIALIDADES FARMACEUTICAS CENTRUM S.A. | 2012-05-29 | 1 | 1 | 1 | 2012-05-29 | 2024-09-23 | 0 | 2026-03-06 | Lista I | View Edit Delete | |||||||||||
| 765808 | 72974 | DURFENTA 100 microgramos/HORA PARCHES TRANSDERMICOS EFG | DURFENTA 100 microgramos/HORA PARCHES TRANSDERMICOS EFG, 10 parches | 100 microgramos/h | 35 | 10 | 28 | 10 parches | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72974/72974_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72974/72974_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1625 | ESPECIALIDADES FARMACEUTICAS CENTRUM S.A. | 2012-05-29 | 1 | 1 | 1 | 2012-05-29 | 2024-09-23 | 0 | 2026-03-06 | Lista I | View Edit Delete | |||||||||||
| 765809 | 75601 | DURFENTA 12 microgramos/HORA PARCHES TRANSDERMICOS EFG | DURFENTA 12 microgramos/HORA PARCHES TRANSDERMICOS EFG, 10 parches | 12 microgramos/h | 35 | 10 | 28 | 10 parches | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75601/75601_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75601/75601_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1625 | ESPECIALIDADES FARMACEUTICAS CENTRUM S.A. | 2012-05-29 | 1 | 1 | 1 | 2012-05-29 | 2024-09-23 | 0 | 2026-03-06 | Lista I | View Edit Delete | |||||||||||
| 765679 | 66216 | AMOXICILINA/ACIDO CLAVULANICO SANDOZ 500 mg/50 mg POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | AMOXICILINA/ACIDO CLAVULANICO SANDOZ 500 mg/50 mg POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 10 viales | 500 mg/50 mg | 45 | 1 | 34 | 10 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66216/66216_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66216/66216_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2004-07-01 | 1 | 1 | 1 | 2004-07-01 | 2024-09-04 | 0 | 2025-06-13 | View Edit Delete | ||||||||||||
| 765608 | 1241835001 | APEXELSIN 5 MG/ML POLVO PARA DISPERSION PARA PERFUSION EFG | APEXELSIN 5 MG/ML POLVO PARA DISPERSION PARA PERFUSION EFG, 1 vial | 100 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1241835001/1241835001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241835001/1241835001_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 67328 | ZENTIVA SPAIN S.L. | 2024-08-21 | 1 | 1 | 1 | 2024-08-22 | 2024-08-21 | 0 | 2024-12-13 | View Edit Delete | ||||||||||||
| 766029 | 89896 | TIOTEPA VIVANTA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | TIOTEPA VIVANTA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial | 100 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89896/89896_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89896/89896_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27271 | VIVANTA GENERICS S.R.O. SUCURSAL EN ESPANA | 2024-12-09 | 1 | 1 | 1 | 2024-12-09 | 2024-12-09 | 0 | 2026-01-08 | View Edit Delete | ||||||||||||
| 766031 | 89897 | TIOTEPA VIVANTA 15 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | TIOTEPA VIVANTA 15 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial | 15 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89897/89897_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89897/89897_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27271 | VIVANTA GENERICS S.R.O. SUCURSAL EN ESPANA | 2024-12-09 | 1 | 1 | 1 | 2024-12-09 | 2024-12-09 | 0 | 2026-01-08 | View Edit Delete | ||||||||||||
| 765872 | 1241848001 | PIASKY 340 MG SOLUCION INYECTABLE Y PARA PERFUSION | PIASKY 340 MG SOLUCION INYECTABLE Y PARA PERFUSION, 1 vial de 2 ml | 340 mg inyectable 2 ml | 45 | 1 | 34 | 1 vial de 2 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241848001/1241848001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241848001/1241848001_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29096 | ROCHE FARMA S.A. | 2024-09-30 | 1 | 1 | 1 | 2024-10-01 | 2024-09-30 | 0 | 2025-07-30 | View Edit Delete | ||||||||||||
| 766907 | 90131 | TIOTEPA SEACROSS 100 MG POLVO PARA CONCETRADO PARA SOLUCION PARA PERFUSION EFG | TIOTEPA SEACROSS 100 MG POLVO PARA CONCETRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial | 100 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90131/90131_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90131/90131_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41980 | PHARMAVIC IBERICA S.L. | 2025-02-10 | 1 | 1 | 1 | 2025-02-11 | 2025-02-10 | 0 | 2025-04-21 | View Edit Delete | ||||||||||||
| 766908 | 90132 | TIOTEPA SEACROSS 15 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | TIOTEPA SEACROSS 15 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial | 15 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90132/90132_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90132/90132_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41980 | PHARMAVIC IBERICA S.L. | 2025-02-10 | 1 | 1 | 1 | 2025-02-11 | 2025-02-10 | 0 | 2025-04-21 | View Edit Delete | ||||||||||||
| 765992 | 02223002IP4 | EVRA 203 MICROGRAMOS/24 HORAS + 33,9 MICROGRAMOS/24 HORAS PARCHE TRANSDERMICO | EVRA 203 MICROGRAMOS/24 HORAS + 33,9 MICROGRAMOS/24 HORAS PARCHE TRANSDERMICO, 9 parches | 203 microgramos/24 h + 33,9 microgramos/24 h | 74 | 9 | 28 | 9 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/02223002IP4/02223002IP4_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/02223002IP4/02223002IP4_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8334 | DIFARMED S.L.U. | 2024-10-15 | 1 | 1 | 1 | 2024-10-16 | 2024-10-15 | 0 | 2024-11-20 | View Edit Delete | ||||||||||||
| 765846 | 74120 | ABATTRA 12 MICROGRAMOS/HORA PARCHES TRANSDERMICOS EFG | ABATTRA 12 MICROGRAMOS/HORA PARCHES TRANSDERMICOS EFG, 10 parches | 12 microgramos/h | 74 | 10 | 28 | 10 parches | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74120/74120_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74120/74120_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13469 | ARISTO PHARMA IBERIA S.L. | 2013-02-01 | 1 | 1 | 1 | 2013-02-01 | 2024-09-27 | 0 | 2025-12-12 | Lista I | View Edit Delete | |||||||||||
| 765848 | 74122 | ABATTRA 50 MICROGRAMOS/HORA PARCHES TRANSDERMICOS EFG | ABATTRA 50 MICROGRAMOS/HORA PARCHES TRANSDERMICOS EFG, 10 parches | 50 microgramos/h | 74 | 10 | 28 | 10 parches | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74122/74122_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74122/74122_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13469 | ARISTO PHARMA IBERIA S.L. | 2013-02-01 | 1 | 1 | 1 | 2013-02-01 | 2024-09-27 | 0 | 2025-12-12 | Lista I | View Edit Delete | |||||||||||
| 765849 | 74123 | ABATTRA 75 MICROGRAMOS/HORA PARCHES TRANSDERMICOS EFG | ABATTRA 75 MICROGRAMOS/HORA PARCHES TRANSDERMICOS EFG, 10 parches | 75 microgramos/h | 74 | 10 | 28 | 10 parches | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74123/74123_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74123/74123_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13469 | ARISTO PHARMA IBERIA S.L. | 2013-02-01 | 1 | 1 | 1 | 2013-02-01 | 2024-09-27 | 0 | 2025-12-12 | Lista I | View Edit Delete | |||||||||||
| 765850 | 74124 | ABATTRA 100 MICROGRAMOS/HORA PARCHES TRANSDERMICOS EFG | ABATTRA 100 MICROGRAMOS/HORA PARCHES TRANSDERMICOS EFG, 10 parches | 100 microgramos/h | 74 | 10 | 28 | 10 parches | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74124/74124_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74124/74124_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13469 | ARISTO PHARMA IBERIA S.L. | 2013-02-01 | 1 | 1 | 1 | 2013-02-01 | 2024-09-27 | 0 | 2025-12-12 | Lista I | View Edit Delete |
Page 170 of 1036, showing 20 records out of 20704 total, starting on record 3381, ending on 3400